Bedel Financial Consulting’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-500
Closed -$17K 426
2022
Q1
$17K Hold
500
0.01% 568
2021
Q4
$16K Hold
500
0.01% 607
2021
Q3
$17K Hold
500
0.01% 575
2021
Q2
$21K Hold
500
0.01% 549
2021
Q1
$18K Hold
500
0.01% 530
2020
Q4
$21K Hold
500
0.01% 443
2020
Q3
$21K Hold
500
0.01% 412
2020
Q2
$22K Hold
500
0.01% 388
2020
Q1
$16K Hold
500
0.01% 410
2019
Q4
$18K Hold
500
0.01% 415
2019
Q3
$17K Hold
500
0.01% 409
2019
Q2
$20K Hold
500
0.01% 394
2019
Q1
$20K Hold
500
0.01% 390
2018
Q4
$16K Hold
500
0.01% 390
2018
Q3
$24K Hold
500
0.02% 357
2018
Q2
$25K Hold
500
0.02% 349
2018
Q1
$26K Buy
+500
New +$26.7K 0.02% 347

Other funds holding FMS

Bedel Financial Consulting's FMS Position: Q2 2022 in Review

Bedel Financial Consulting sold out of Fresenius Medical Care (FMS) in Q2 2022, closing a stake of 500 shares — an estimated $17K sold.

Bedel Financial Consulting first reported a position in FMS in Q1 2018 and held it in 17 quarters. The position peaked at $26K in Q1 2018. 166 funds tracked by Wall St. Rank hold FMS as of Q2 2022.

  • Bedel Financial Consulting reported no remaining Fresenius Medical Care position as of Q2 2022 after selling out during the quarter.
  • Bedel Financial Consulting sold 500 Fresenius Medical Care shares in Q2 2022, an estimated $17K.
  • Bedel Financial Consulting first reported a position in Fresenius Medical Care in Q1 2018 and held it in 17 quarters.
  • Bedel Financial Consulting's Fresenius Medical Care position peaked at $26K in Q1 2018.
  • 166 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2022.

Based on Bedel Financial Consulting's 13F filing for Q2 2022, filed 4 Aug 2022.